Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Thrombocytopenia-Absent Radius Syndrome Clinical Presentation

  • Author: John K Wu, MBBS, MSc, FRCPC; Chief Editor: Hassan M Yaish, MD  more...
 
Updated: May 09, 2016
 

History

Episodes of thrombocytopenia begin in the neonatal period in patients with thrombocytopenia-absent radius (TAR) syndrome.[14]

About 50% of affected infants are symptomatic in the first week of life, and 90% are symptomatic by the age of 4 months. Thrombocytopenia can fluctuate over time. Therefore, if TAR syndrome is strongly suspected on the basis of one normal platelet count, repeating the blood work is recommended.

Thrombocytopenic episodes are most frequent during the first 2 years of life, when they increase the mortality rate secondary to intracranial hemorrhage. With increasing age, the recurrence of thrombocytopenic episodes decreases. Thrombocytopenia can improve to a near-normal state.

Nonspecific stress, infection, and diet (eg, allergy to cow's milk) may precipitate episodes. Symptoms include purpura, petechiae, epistaxis, melena, hemoptysis, hematuria, hematemesis, and, rarely, intracranial hemorrhage.

Symptomatic cow's-milk allergy is associated with 47% of all cases of TAR syndrome, and patients may present as vomiting, bloody diarrhea, and failure to thrive.

Mental retardation is associated with about 7% of all cases of TAR syndrome. The association of TAR with mental retardation is presumed to be secondary to complications from intracranial hemorrhage precipitated by thrombocytopenia.

Symptoms of acute intracranial hemorrhage in an infant are associated with poor feeding, lethargy, irritability, and fluctuating levels of consciousness.

Structural causes that predispose the patient to mental retardation and other neuropsychiatric disorders (psychosis) have been suggested.[15]

Hypoplasia of the cerebellar vermis and corpus callosum has been reported in this syndrome.[16]

Next

Physical

Upper-extremity abnormalities range from isolated absent radii to phocomelia. Abnormalities include the following:

  • Bilateral radial aplasia
  • Radial club hand
  • Hypoplastic carpals and phalanges
  • Hypoplastic ulnae, humeri, and shoulder girdles
  • Syndactyly and clinodactyly of fingers and toes
  • Selective hypoplasia of middle phalanx, fifth digit
  • Altered palmar contours

Greenhalgh and colleagues examined 34 patients with TAR syndrome.[12] Their findings demonstrated how the length of the upper limb can affect the patient's functional ability. They divided upper-limb defects into 3 categories of severity, as follows:

  • The first group (71%) had mild defects consisting of radial aplasia with various degrees of ulnar and humeral hypoplasia. The patients also had normal shoulder girth and, hence, near-normal upper-body strength, but splints were still useful for periods of prolonged activity of the upper limbs.
  • The second group (18%) had increased degrees of limb shortening, humeral hypoplasia, and underdevelopment of the shoulder girth with decreased upper-body strength. Splints were also useful in this group.
  • The last group was the most affected, with severe ulnar and humeral shortening and phocomelia.

Lower-extremity anomalies occur in 46% of patients and vary from clinically undetectable changes to phocomelia. These anomalies are usually less severe than those of the upper limbs. Abnormalities include the following:

  • Hip dislocation
  • Femoral torsion
  • Tibial torsion
  • Valgus and varus foot deformities
  • Deformity of the knee (eg, absence of the patella, patellar dislocation)
  • Absent tibiofibular joint
  • Abnormal toe placement
  • Fifth toe overlapping the fourth

Cardiac anomalies occur in 15-33% of patients and include the following:

Facial anomalies (which occur in 53% of patients) include the following:

  • Micrognathia (3-30% of patients)
  • Tall, broad forehead
  • Facial hemangiomas
  • Hypertelorism
  • Low, posteriorly rotated ears

Other abnormalities are numerous and include the following:

  • Asymmetric first rib
  • Cervical rib, cervical spina bifida, fused cervical spine, and nuchal folds
  • Uterine anomalies
  • Dorsal pedal edema
  • Hyperhidrosis
  • Short stature (95% of patients at or below the 50th percentile)
  • Other skeletal malformations
  • Renal anomalies (23% of patients), eg, duplex ureter, mild renal pelvis dilatation, horseshoe kidneys
  • Intracranial vascular malformation
  • Sensorineural hearing loss
  • Scoliosis
  • GI anomalies (eg, esophageal atresia, tracheoesophageal fistula, anal atresia)
  • Annular pancreas

Only patients with TAR syndrome consistently have bilateral absence of the radii with the presence of thumbs and 4 digits. In distinguishing TAR from other syndromes involving skeletal abnormalities of the upper extremities, the following features may be of assistance:

  • Patients with TAR syndrome always have thumbs, but thumbs are usually absent or hypoplastic in patients with Fanconi anemia and radial defects. Fanconi anemia is also associated with chromosomal fragility, a rare onset of thrombocytopenia before age 1 year, and pancytopenia in children aged 5-10 years. A reliable diagnostic test is a chromosomal breakage study.
  • Thumb abnormalities include absent, hypoplastic, and triphalangeal thumbs in Holt-Oram syndrome, and blood counts are normal. The patient often has a family history of heart and limb defects due to the autosomal dominant pattern of inheritance.
  • Thrombocytopenia is not often observed in Roberts syndrome (Roberts-SC phocomelia). Most patients with this syndrome have microcephaly and mental retardation.
  • Radial hypoplasia is found in patients with Aase syndrome, but the thumb is triphalangeal. Hypoplastic anemia is the usual presentation, similar to that of Blackfan-Diamond syndrome. Thrombocytopenia is not a feature.
Previous
Next

Causes

Causes of TAR syndrome are not fully elucidated. See Pathophysiology.

Previous
 
 
Contributor Information and Disclosures
Author

John K Wu, MBBS, MSc, FRCPC Clinical Professor, Department of Pediatrics, Division of Hematology-Oncology-BMT, University of British Columbia Faculty of Medicine, British Columbia Children's Hospital, Canada

John K Wu, MBBS, MSc, FRCPC is a member of the following medical societies: American Society of Hematology, International Society on Thrombosis and Haemostasis, Canadian Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

Suzan Williams, MD, MSc, FRCPC Staff Physician, Division of Hematology, The Hospital for Sick Children, Canada

Suzan Williams, MD, MSc, FRCPC is a member of the following medical societies: American Academy of Pediatrics, American Society of Hematology, Canadian Medical Association, Royal College of Physicians and Surgeons of Canada, Canadian Paediatric Society, College of Physicians and Surgeons of Ontario, Ontario Medical Association

Disclosure: Nothing to disclose.

Michelle P Wong, MD Staff Physician, Department of Hematopathology, University of British Columbia Faculty of Medicine, Canada

Disclosure: Nothing to disclose.

Christopher Wu, MD Resident Physician, Department of Urology, McMaster University School of Medicine, Canada

Christopher Wu, MD is a member of the following medical societies: American Urological Association, Canadian Urological Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

James L Harper, MD Associate Professor, Department of Pediatrics, Division of Hematology/Oncology and Bone Marrow Transplantation, Associate Chairman for Education, Department of Pediatrics, University of Nebraska Medical Center; Associate Clinical Professor, Department of Pediatrics, Creighton University School of Medicine; Director, Continuing Medical Education, Children's Memorial Hospital; Pediatric Director, Nebraska Regional Hemophilia Treatment Center

James L Harper, MD is a member of the following medical societies: American Society of Pediatric Hematology/Oncology, American Federation for Clinical Research, Council on Medical Student Education in Pediatrics, Hemophilia and Thrombosis Research Society, American Academy of Pediatrics, American Association for Cancer Research, American Society of Hematology

Disclosure: Nothing to disclose.

Chief Editor

Hassan M Yaish, MD Medical Director, Intermountain Hemophilia and Thrombophilia Treatment Center; Professor of Pediatrics, University of Utah School of Medicine; Director of Hematology, Pediatric Hematologist/Oncologist, Department of Pediatrics, Primary Children's Medical Center

Hassan M Yaish, MD is a member of the following medical societies: American Academy of Pediatrics, New York Academy of Sciences, American Medical Association, American Society of Hematology, American Society of Pediatric Hematology/Oncology, Michigan State Medical Society

Disclosure: Nothing to disclose.

Additional Contributors

J Martin Johnston, MD Associate Professor of Pediatrics, Mercer University School of Medicine; Director of Hematology/Oncology, The Children's Hospital at Memorial University Medical Center; Consulting Oncologist/Hematologist, St Damien's Pediatric Hospital

J Martin Johnston, MD is a member of the following medical societies: American Academy of Pediatrics, American Society of Pediatric Hematology/Oncology, International Society of Paediatric Oncology

Disclosure: Nothing to disclose.

References
  1. Elmakky A, Stanghellini I, Landi A, Percesepe A. Role of Genetic Factors in the Pathogenesis of Radial Deficiencies in Humans. Curr Genomics. 2015 Aug. 16 (4):264-78. [Medline]. [Full Text].

  2. Ballmaier M, Schulze H, Strauss G, et al. Thrombopoietin in patients with congenital thrombocytopenia and absent radii: elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin. Blood. 1997 Jul 15. 90(2):612-9. [Medline]. [Full Text].

  3. Sekine I, Hagiwara T, Miyazaki H, et al. Thrombocytopenia with absent radii syndrome: studies on serum thrombopoietin levels and megakaryopoiesis in vitro. J Pediatr Hematol Oncol. 1998 Jan-Feb. 20(1):74-8. [Medline].

  4. Geddis AE. Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii. Hematol Oncol Clin North Am. 2009 Apr. 23(2):321-31. [Medline]. [Full Text].

  5. Fleischman RA, Letestu R, Mi X, et al. Absence of mutations in the HoxA10, HoxA11 and HoxD11 nucleotide coding sequences in thrombocytopenia with absent radius syndrome. Br J Haematol. 2002 Feb. 116(2):367-75. [Medline].

  6. Klopocki E, Schulze H, Strauss G, et al. Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome. Am J Hum Genet. 2007 Feb. 80(2):232-40. [Medline].

  7. Albers CA, Newbury-Ecob R, Ouwehand WH, Ghevaert C. New insights into the genetic basis of TAR (thrombocytopenia-absent radii) syndrome. Curr Opin Genet Dev. 2013 Jun. 23(3):316-23. [Medline].

  8. Albers CA, Paul DS, Schulze H, Freson K, Stephens JC, Smethurst PA. Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome. Nat Genet. 2012 Apr. 44(4):435-9, S1-2. [Medline].

  9. Le Hir H, Gatfield D, Izaurralde E, Moore MJ. The exon-exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay. EMBO J. 2001 Sep 3. 20(17):4987-97. [Medline].

  10. Le Hir H, Izaurralde E, Maquat LE, Moore MJ. The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions. EMBO J. 2000 Dec 15. 19(24):6860-9. [Medline].

  11. Hedberg VA, Lipton JM. Thrombocytopenia with absent radii. A review of 100 cases. Am J Pediatr Hematol Oncol. 1988 Spring. 10(1):51-64. [Medline].

  12. Greenhalgh KL, Howell RT, Bottani A, et al. Thrombocytopenia-absent radius syndrome: a clinical genetic study. J Med Genet. 2002 Dec. 39(12):876-81. [Medline]. [Full Text].

  13. Hall JG, Levin J, Kuhn JP, et al. Thrombocytopenia with absent radius (TAR). Medicine (Baltimore). 1969 Nov. 48(6):411-39. [Medline].

  14. Toriello HV. Thrombocytopenia-absent radius syndrome. Semin Thromb Hemost. 2011 Sep. 37(6):707-12. [Medline].

  15. Sachdev P. Brief psychosis in thrombocytopenia-absent radius syndrome: a case report. Aust N Z J Psychiatry. 2005 Sep. 39(9):841-2. [Medline].

  16. Skorka A, Bielicka-Cymermann J, Gieruszczak-Bialek D, Korniszewski L. Thrombocytopenia-absent radius (tar) syndrome: a case with agenesis of corpus callosum, hypoplasia of cerebellar vermis and horseshoe kidney. Genet Couns. 2005. 16(4):377-82. [Medline].

  17. Thompson AA, Nguyen LT. Amegakaryocytic thrombocytopenia and radio-ulnar synostosis are associated with HOXA11 mutation. Nat Genet. 2000 Dec. 26 (4):397-8. [Medline].

  18. Thompson AA, Woodruff K, Feig SA, Nguyen LT, Schanen NC. Congenital thrombocytopenia and radio-ulnar synostosis: a new familial syndrome. Br J Haematol. 2001 Jun. 113 (4):866-70. [Medline].

  19. Weinblatt M, Petrikovsky B, Bialer M, et al. Prenatal evaluation and in utero platelet transfusion for thrombocytopenia absent radii syndrome. Prenat Diagn. 1994 Sep. 14(9):892-6. [Medline].

  20. Coccia P, Ruggiero A, Mastrangelo S, Attinà G, Scalzone M, Pittiruti M, et al. Management of children with thrombocytopenia-absent radius syndrome: an institutional experience. J Paediatr Child Health. 2012 Feb. 48(2):166-9. [Medline].

  21. Dempfle CE, Burck C, Grutzmacher T et al. Increase in platelet count in response to rHuEpo in patient with thromboctopenia and absent radii syndrome. Blood. 2001. 97 (7):2189-90. [Medline]. [Full Text].

  22. Aquino VM, Mustafa MM, Vackus L et al. Recombinant interleukin-6 in the treatment of congenital thrombocytopenia associated with absent radii. J Pediatr Hematol Oncol. 1998. 20 (5):474-6. [Medline].

  23. Al Kaissi A, Girsch W, Kenis V, et al. Reconstruction of limb deformities in patients with thrombocytopenia-absent radius syndrome. Orthop Surg. 2015 Feb. 7 (1):50-6. [Medline].

  24. Letestu R, Vitrat N, Masse A, et al. Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome. Blood. 2000 Mar 1. 95(5):1633-41. [Medline]. [Full Text].

  25. [Guideline] Finnish Medical Society Duodecim. Thrombocytopenia. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2007 Apr 27. [Full Text].

  26. Guastadisegni MC, Roberto R, L'Abbate A, Palumbo O, Carella M, Giordani L, et al. Thrombocytopenia-absent-radius syndrome in a child showing a larger 1q21.1 deletion than the one in his healthy mother, and a significant downregulation of the commonly deleted genes. Eur J Med Genet. 2012 Feb. 55(2):120-3. [Medline].

 
Previous
Next
 
Infant with thrombocytopenia-absent radius syndrome. The arms and forearms are shortened, with radial deviation of both hands because of the absence of bilateral radii. The legs are normal. See also Media files 2 and 3.
Same infant as in Media files 1 and 3. Close-up photograph of arm and forearm (volar aspect). Note the petechiae.
Same infant as in Media files 1 and 2. Close-up photograph of arm and forearm (dorsal aspect).
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.